Marcal Paper, a leading paper products company based in the United States, acquired BiOrigin Specialty Products, a Canadian manufacturer of specialty paper and tissue grades, on July 1, 2026. The deal's financial terms were not disclosed.
| Acquirer | Marcal Paper (US) |
| Target | BiOrigin Specialty Products (CA) |
| Type of Deal | Acquisition |
| Deal Value | Undisclosed |
| Closing Date | 2026-07-01 |
| Announcement Date | 2026-07-01 |
| Buy-side Advisors | City Capital Advisors |
| Sell-side Advisors | Not Disclosed |
| Legal Buy-side Advisors | Not Disclosed |
| Legal Sell-side Advisors | Not Disclosed |
The acquisition allows Marcal Paper to expand its presence in the specialty paper and tissue market, particularly for niche products used in food packaging and high-end consumer applications. BiOrigin Specialty Products operates a mill located in St. Catharines, Ontario, which has been a significant producer of specialty papers.
Strategic Rationale
The acquisition is driven by Marcal Paper's strategic goal to streamline its operations and focus on high-margin products that align with the company's long-term growth objectives. By integrating BiOrigin Specialty Products, Marcal Paper aims to strengthen its position in North America’s specialty paper market.
Financial Context
The deal is part of a broader strategy by Marcal Paper to consolidate its portfolio and improve operational efficiency. The company believes that this acquisition will enhance revenue growth opportunities through the diversification of product offerings, which includes food packaging products and various tissue grades.
Outlook
Following the transaction, Marcal Paper is expected to leverage BiOrigin's production capabilities and technology assets to further innovate in its product range. The company will also look to increase market penetration through expanded distribution networks in North America and potentially other regions.